関連する実験動画
Updated: May 5, 2026

10:58
Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
Published on: July 25, 2013
17.1K
De Novo バクテリア粘着剤のミニタンパク質阻害剤の設計
bioRxiv : the preprint server for biology
|September 2, 2025
まとめ
タンパク質の設計は 細菌の粘着を阻害することで 新しい抗菌物質を作り出します これらの新薬は 抗生物質なしで 尿路感染症を効果的に治療し 予防します
科学分野:
- タンパク質工学
- 微生物学
- 感染症
背景:
- 多剤耐性細菌感染症は 世界的に重大な健康上の脅威となっています
- バクテリアのアデシンは,宿主-病原体相互作用と感染を媒介する重要な毒性因子です.
- 尿路感染症は,尿病原性細菌によって引き起こされ,かなりの罹病率と死亡率をもたらします.
研究 の 目的:
- タンパク質の設計が細菌アデシンを標的とした新しい抗菌剤を生成することを実証する.
- エシェリキア・コライとアチネトバクテリア・バウマンニーの特定のアデシンに対する高親和のミニタンパク質結合剤を開発する.
- これらの設計された抗菌薬の尿路感染症の予防と治療における治療の可能性を評価する.
主な方法:
- 高親和のミニタンパク質結合剤の設計
- FimHはEからアデシンをターゲットにしています. コリとAbp1D/Abp2DアデシンがAから バウマンニ
- バクテリアの認識を妨害し,バイオフィルム形成を阻害し,尿路感染症の治療/予防における抗体特異性,安定性および有効性のインビトロおよびインビボの評価.
主要な成果:
- 標的細菌アデシンに対する高い親和性と特異性を持つミニタンパク質を成功裏に設計した.
- 細菌の宿主受容体の認識とバイオフィルム形成の阻害が実証されています.
- 合併症のない尿路感染症と,カテーテルによる尿路感染症の両方の治療と予防における有効性を検証した.
結論:
- タンパク質の設計は,細胞外細菌の毒性因子を標的として,新しい抗菌剤を開発するための一般化可能な戦略を提供します.
- 設計されたアデシン・アンタゴニストは,抗生物質を節約する治療と細菌感染症の予防のための,次世代の治療薬の有望なクラスです.
- このアプローチにより 病気の発生を妨害し 抗生物質耐性に対抗する効果的な治療法が 迅速に得られます
関連する概念動画
Enzyme Inhibition
72.5K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
72.5K
Cytoskeletal Proteins in Bacteria
3.5K
Bacterial cells were initially considered simple, randomly organized structures lacking a cytoskeleton. However, the discovery of cytoskeleton homologs in bacteria led to the change of this opinion. Bacterial cytoskeletal filaments regulate the cell shape, cell polarity, cell division, and partitioning of plasmids during cell division. It was later discovered that bacterial cytoskeletal proteins, mainly actin and tubulin homologs, are diverse compared to their eukaryotic counterparts. On the...
3.5K
Adherens Junctions
5.8K
Strong contact points between adjacent cells anchor them to each other, forming tissues. Such anchoring junctions are of two types – adherens junctions and desmosomes. Adherens junctions are abundant in tissues such as epithelium and endothelium, forming a continuous zone of adhesion called the adhesion belt. In other tissues, such as heart muscle, they appear as clusters, linking the cells to produce coordinated heart muscle contraction.
Adherens Junctions are Dynamic
Adherens Junctions are Dynamic
5.8K
Antimicrobial Proteins
10.6K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
10.6K
Inhibitors of Gram-positive Cell Wall Synthesis
216
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
216
Inhibitors of Bacterial Protein Synthesis
127
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
127

